Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
01/27/2009 | US7482460 Doxepin analogs and methods of use thereof |
01/27/2009 | US7482458 Quinoline derivatives |
01/27/2009 | US7482455 Chemical compounds |
01/27/2009 | US7482449 Combining strong base with phenyl isonicotinamide in aprotic solvents to form solution, then reacting with cyclohexanone carboxylic acid or ester and water, and acidifying the solution to obtain chemical intermediates for neuropeptide Y antagonists used for treating bulimia, obesity or diabetes |
01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
01/27/2009 | US7482370 Compounds for the treatment of inflammatory disorders |
01/27/2009 | US7482368 Triamide-substituted heterobicyclic compounds |
01/27/2009 | US7482366 Modulators of LXR |
01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
01/27/2009 | US7482352 Such as N6-[6-(2-dimethylaminoethylamino)-4-methylsulfanyl-[1,3,5]triazin-2-yl]-2-methylquinoline-4,6-diamine, which stabilizes DNA in G-quadruplex structures (guanine tetrads); anticancer agents |
01/27/2009 | US7482350 4,5-disubstituted-2-aryl pyrimidines |
01/27/2009 | US7482349 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5- dihydro-4H-imidazol-4-one |
01/27/2009 | US7482340 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
01/27/2009 | US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
01/27/2009 | CA2389280C Triazoles as farnesyl transferase inhibitors |
01/27/2009 | CA2388646C Methods and compositions utilizing quinazolinones |
01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
01/27/2009 | CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
01/22/2009 | WO2009012482A2 5-membered heterocyclic amides and related compounds |
01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
01/22/2009 | WO2009010846A2 Amorphous form of darifenacin hydrobromide and processes for the preparation thereof |
01/22/2009 | WO2009010521A2 Nir-inert substrates comprising bis-oxodihydroindolylen-benzodifuranones |
01/22/2009 | WO2009010477A1 Piperidine-4-acetic acid derivatives and their use |
01/22/2009 | WO2009010260A2 Condensed anthranilamide insecticides |
01/22/2009 | WO2009010230A2 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast |
01/22/2009 | WO2008130021A3 Heterocyclic hydrazide compound and pesticidal use of the same |
01/22/2009 | WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
01/22/2009 | US20090023925 N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles |
01/22/2009 | US20090023918 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
01/22/2009 | US20090023917 Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms |
01/22/2009 | US20090023785 6-substituted nicotinamide derivatives as opioid receptor antagonists |
01/22/2009 | US20090023777 Substituted 4-amino-benzylpiperidine compounds |
01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
01/22/2009 | US20090023749 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia |
01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
01/22/2009 | US20090023728 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof |
01/22/2009 | US20090023725 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors |
01/22/2009 | US20090023719 4-(Benzo[d]dioxol-4-ylamino)- or 4-(indazol-4-ylamino)- substituted 2,4-pyrimidinediamine derivatives: N4-(5-chlorobenzo[d][1,3]dioxol-4-yl)-N2-(2,6-dimorpholinopyridin-4-yl)pyrimidine-2,4-diamine; N-(4,6-dimorpholin-4-ylpyrimidin-2-yl)-N'-(1H-indazol-4-yl)-N'-methyl-pyrimidine-2,4-diamine; anticancer |
01/22/2009 | US20090023710 Compound |
01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
01/22/2009 | DE102006014320B4 Inhibitoren der löslichen Adenylatzklase Inhibitors of soluble Adenylatzklase |
01/22/2009 | CA2694475A1 Quinazolinamide derivatives |
01/22/2009 | CA2693880A1 Pyrimidine derivatives 934 |
01/22/2009 | CA2692896A1 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast |
01/22/2009 | CA2691507A1 5-membered heterocyclic amides and related compounds |
01/22/2009 | CA2690761A1 Benzimidazole poly(adp-ribose)polymerase inhibitors |
01/21/2009 | EP2016088A2 Process for preparing disulphides and thiosulphinates and compounds prepared |
01/21/2009 | EP2016074A1 Inhibitors of c-fms kinase |
01/21/2009 | EP2016070A1 Inhibitors of c-fms kinase |
01/21/2009 | EP2016064A2 Methods for the preparation of pyrazole-containing compounds |
01/21/2009 | EP2016060A1 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof |
01/21/2009 | EP2016057A1 C-fms kinase inhibitors |
01/21/2009 | EP2016049A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors |
01/21/2009 | EP1674460B1 Chromene compound |
01/21/2009 | EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
01/21/2009 | EP1626964B1 New benzimidazole derivatives |
01/21/2009 | EP1613315B1 Quinoline-2-one-derivatives for the treatment of airways diseases |
01/21/2009 | EP1549619B1 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
01/21/2009 | EP1531816B1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
01/21/2009 | EP1499610B1 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
01/21/2009 | EP1339690B1 N-type calcium channel antagonists for the treatment of pain |
01/21/2009 | CN101351524A Use of rylene derivatives as photosensitizers in solar cells |
01/21/2009 | CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
01/21/2009 | CN100453534C Substituted dihydropyrimidinone preparation using polyaniline salt catalyst |
01/20/2009 | US7479562 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects of dry-mouth and constipation; biphenyl carbamate derivatives; biphenyl-2-ylcarbamic acid 1-(3-(3-[3-(4-hydroxybenzylamino)propyl]-2-oxoimidazolidin-1-yl)propyl)piperidin-4-yl ester |
01/20/2009 | US7479559 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation |
01/20/2009 | US7479504 Edg receptor agonists |
01/20/2009 | US7479501 Heteroaryl-cyclic acetals |
01/20/2009 | US7479495 N-heterocyclic inhibitors of TNF-α expression |
01/20/2009 | US7479494 3-monosubstituted tropane derivatives as nociceptin receptor ligands |
01/20/2009 | US7479471 Applying to plants, seeds |
01/20/2009 | CA2528493C Medicinal composition containing triazole compound |
01/20/2009 | CA2521030C 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
01/20/2009 | CA2499698C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
01/20/2009 | CA2339961C Isoquinoline derivatives with angiogenesis inhibiting activity |
01/20/2009 | CA2322204C 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents |
01/20/2009 | CA2293368C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
01/20/2009 | CA2220759C 1,4-benzodioxin derivatives |
01/15/2009 | WO2009009059A1 Spiro compounds as antagonists of tgf-beta |
01/15/2009 | WO2009007987A1 An improved process for the preparation of alfuzosin and its novel polymorph |
01/15/2009 | WO2009007399A1 New compounds as hsp90 inhibitors |
01/15/2009 | WO2008142140A3 Novel 2,3-diamino-quinazolinone derivatives and their medical use |
01/15/2009 | WO2008128622A3 Pyridine compounds for liquid-crystalline mixtures |
01/15/2009 | US20090018346 Amorphous Form Of Darifenacin Hydrobromide And Processes For The Preparation Thereof |
01/15/2009 | US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use |
01/15/2009 | US20090018177 Propane-1,3-Dione Derivative or Salt Thereof |
01/15/2009 | US20090018157 Chemical compounds |
01/15/2009 | US20090018145 Compositions and their use as anti-tumor agents |
01/15/2009 | US20090018133 Novel Adamantane Derivatives |
01/15/2009 | US20090018113 Novel Cylopenta[B]Benzofuran Derivatives and the Utilization Thereof |
01/15/2009 | US20090018087 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
01/15/2009 | US20090017546 Fluorescent isotope tags and their method of use |
01/14/2009 | EP2014657A1 Diaminopyrimidines as modulators for an EP2 receptor |
01/14/2009 | EP2014656A2 New heteocyclic h3 antagonists |